STOCK TITAN

Coherus BioSciences to Report Third Quarter 2021 Financial Results on November 8th

(Neutral)
(Neutral)
Tags
conferences earnings

Rhea-AI Summary

Coherus BioSciences (Nasdaq: CHRS) will announce its third-quarter 2021 financial results after the market closes on November 8, 2021. A conference call and webcast will follow at 5 p.m. ET, where management will discuss the results and provide a business update. Investors can access the financial results via the company's website after the announcement. Additionally, the conference call can be joined through specified dial-in numbers and a conference ID. Coherus aims to enhance access to cost-effective medicines for impactful patient care.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction – CHRS

+1.49%
+1.49% Session move

In the trading session that priced this news, CHRS gained 1.49%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

REDWOOD CITY, Calif., Oct. 29, 2021 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus”, Nasdaq: CHRS), today announced that its third quarter 2021 financial results will be released after market close on Monday, November 8, 2021. Starting at 5 p.m. ET, Coherus’ management team will host a conference call and webcast to discuss financial results and provide a general business update.

After releasing third quarter financial results, the Company will post them on the Coherus website at https://investors.coherus.com.

Conference Call Information

When: Monday, Nov. 8, 2021, starting at 5 p.m. ET
Dial -in: (844) 452-6826 (Toll-Free U.S. and Canada) or (765) 507-2587 (International)
Conference ID: 1838568

Webcast: https://investors.coherus.com/upcoming-events

Please dial-in 15 minutes early to ensure a timely connection to the call.

About Coherus BioSciences

Coherus is a commercial stage biopharmaceutical company with the mission to increase access to cost-effective medicines that can have a major impact on patients’ lives and to deliver significant savings to the health care system. For additional information, please visit www.coherus.com.

Coherus Contact Information:
Cheston Turbyfill
Coherus BioSciences, Inc.
IR@coherus.com


FAQ

When will Coherus BioSciences release its Q3 2021 financial results?

Coherus BioSciences will release its Q3 2021 financial results after market close on November 8, 2021.

What time is the conference call for Coherus BioSciences Q3 2021 results?

The conference call will take place at 5 p.m. ET on November 8, 2021.

How can I access the Q3 2021 financial results for Coherus BioSciences?

The Q3 2021 financial results will be posted on Coherus' investor website after the announcement.

What is the conference ID for the Coherus BioSciences Q3 2021 conference call?

The conference ID for the call is 1838568.